CEL-SCI Corp. (CVM)
1.35
-0.03
(-2.17%)
USD |
NYAM |
Jun 09, 14:00
CEL-SCI SG&A Expense (Quarterly) : 1.559M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Agenus, Inc. | 6.86M |
| Amgen, Inc. | 1.602B |
| BioCryst Pharmaceuticals, Inc. | 94.55M |
| Imunon, Inc. | 1.969M |
| Curis, Inc. | 5.07M |